Arrowhead Pharmaceuticals, Inc. financial data

Symbol
ARWR on Nasdaq
Industry
Pharmaceutical Preparations
Location
177 E Colorado Blvd, Suite 700, Pasadena, CA
State of incorporation
DE
Fiscal year end
September 30
Former names
ARROWHEAD RESEARCH CORP (to 4/6/2016), INTERACTIVE GROUP INC (to 1/9/2004), INTERACTIVE INC (to 2/13/2002)
Latest financial report
10-K - Q3 2024 - Nov 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 586 % +10.7%
Return On Equity -200 % -273%
Return On Assets -66.5 % -171%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124M shares +0.43%
Common Stock, Shares, Outstanding 124M shares +15.9%
Entity Public Float 3B USD +30.4%
Common Stock, Value, Issued 217K USD +8.5%
Weighted Average Number of Shares Outstanding, Basic 120M shares +12.2%
Weighted Average Number of Shares Outstanding, Diluted 120M shares +12.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.55M USD -98.5%
General and Administrative Expense 98.8M USD +6.71%
Operating Income (Loss) -601M USD -193%
Nonoperating Income (Expense) -11.4M USD -664%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -612M USD -197%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -599M USD -192%
Earnings Per Share, Basic -5 USD/shares -160%
Earnings Per Share, Diluted -5 USD/shares -160%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69.4M USD -34.1%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 4.97M USD +23.3%
Assets, Current 695M USD +67%
Property, Plant and Equipment, Net 386M USD +33%
Operating Lease, Right-of-Use Asset 45.3M USD -0.09%
Other Assets, Noncurrent 4.48M USD +37.5%
Assets 1.14B USD +48.9%
Accounts Payable, Current 11.4M USD -68.2%
Employee-related Liabilities, Current 22M USD +22.4%
Accrued Liabilities, Current 63M USD +58.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 103M USD -2.17%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 111M USD +6.14%
Other Liabilities, Noncurrent 669K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 4.75M USD
Retained Earnings (Accumulated Deficit) -1.63B USD -58.4%
Stockholders' Equity Attributable to Parent 185M USD -31.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 191M USD -33.5%
Liabilities and Equity 1.14B USD +48.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -118M USD -56%
Net Cash Provided by (Used in) Financing Activities 267K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 64.8M USD
Common Stock, Shares Authorized 290M shares 0%
Common Stock, Shares, Issued 124M shares +15.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 94.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 103M USD -7.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 449M USD +57.7%
Deferred Tax Assets, Gross 473M USD +55.4%
Operating Lease, Liability 117M USD +1.91%
Payments to Acquire Property, Plant, and Equipment 68.7M USD +76.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -154M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid 189M USD -2.66%
Property, Plant and Equipment, Gross 444M USD +33.7%
Operating Lease, Liability, Current 6.34M USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.8M USD +5.33%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.5M USD +44%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71.2M USD -9.36%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15M USD -2.39%
Deferred Tax Assets, Operating Loss Carryforwards 103M USD +69.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 16.6M USD +14.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.6M USD -6.17%
Operating Lease, Payments 11M USD +112%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD 0%
Depreciation, Depletion and Amortization 16.9M USD +57.9%
Share-based Payment Arrangement, Expense 67.1M USD -14.1%
Interest Expense 23M USD +43.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%